Updated Nov. 7, 2013 at 4:45 p.m.

Premium Lock Salix to acquire San Diego pharma Santarus for $2.6B

Published: 2013-11-07 16:33:00
Updated: 2013-11-07 16:45:27

Print this blog post
Salix Salix Pharmaceuticals announced on Monday a 62 percent increase in its first quarter revenue for 2012.

Salix, a specialty pharmaceutical company focused on gastrointestinal treatments, said it will acquire all of the outstanding common stock of Santarus at the price of $32 per share, a 37.9 premium over the company's Thursday closing price of $23.20...

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll